🇺🇸 PTGX — Protagonist Therapeutics, Inc.

Salud Compra fuerte
← Volver

Precio actual

140,24 USD

Máx. histórico

158,62

78 días

Caída desde máximo

-11,59%

Rango 52 semanas

75,44 – 160,81

Variación hoy

+0,62%

Cierre anterior

139,37

Rango de hoy

139,91 – 144,27

Volumen hoy

673.087

Peor caída histórica

-85,79%

01/09/2021 → 13/06/2022

Recuperado en 1001 días

Volatilidad anualizada ⓘ

89,34%

Información
Nombre completo
Protagonist Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
141
PER ⓘ
136,16 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
178,57 USD (puede no estar actualizado)
Primera cotización
11/08/2016
Precio actualizado
hace 16 horas
Sobre la empresa

Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States. It develops Icotyde, a first-in-class investigational targeted oral peptide for the treatment of adults and pediatric patients 12 years of age and older with moderate-to-severe plaque psoriasis; and Rusfertide, a first-in-class investigational injectable mimetic of the natural hormone hepcidin in Phase 3 development for the treatment of the rare blood disorder polycythemia vera. The company is also developing PN-881, a potential best-in-class oral peptide IL-17 antagonist, for the treatment of immune-mediated skin diseases in Phase 1 clinical trials; PN-477 and PN-458, which are development candidates for the treatment of obesity; PN-8047, an orally administered hepcidin functional mimetic small molecule; L-4R alpha antagonist for the treatment of atopic dermatitis and moderate-to-severe asthma; and amylinR-based oral and subcutaneous mono- and poly-agonists for the treatment of obesity. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
02/02/2024 28,47 28,47 26,30 26,49 -7,12% 7,62% 1.212.900
01/02/2024 26,60 29,65 25,07 28,52 +14,03% 17,22% 4.621.600
31/01/2024 25,51 25,87 24,91 25,01 -2,38% 3,76% 696.100
30/01/2024 26,48 26,67 25,38 25,62 -3,76% 4,87% 494.500
29/01/2024 25,12 26,77 24,30 26,62 +6,78% 9,83% 1.172.000
26/01/2024 24,37 25,53 24,23 24,93 +2,47% 5,33% 910.100
25/01/2024 24,93 25,00 24,21 24,33 -0,86% 3,17% 662.000
24/01/2024 25,25 25,47 24,49 24,54 -1,76% 3,88% 889.300
23/01/2024 25,29 25,55 24,39 24,98 -0,08% 4,61% 610.500
22/01/2024 25,03 25,46 24,81 25,00 +0,93% 2,60% 567.900
19/01/2024 24,20 24,87 23,89 24,77 +3,38% 4,05% 536.500
18/01/2024 24,85 25,25 23,17 23,96 -2,96% 8,36% 393.900
17/01/2024 24,16 24,69 23,91 24,69 +0,24% 3,23% 486.900
16/01/2024 25,63 25,74 24,41 24,63 -4,90% 5,20% 626.700
12/01/2024 24,63 26,06 24,49 25,90 +6,06% 6,35% 1.105.300
11/01/2024 25,52 26,11 24,13 24,42 -6,79% 7,76% 863.600
10/01/2024 25,38 28,10 25,29 26,20 +3,19% 11,07% 2.328.600
09/01/2024 22,73 26,24 22,73 25,39 +10,30% 15,44% 1.252.000
08/01/2024 21,77 23,06 21,71 23,02 +5,64% 6,20% 622.500
05/01/2024 22,70 22,79 21,43 21,79 -4,51% 5,99% 775.300
04/01/2024 22,68 23,64 22,44 22,82 +1,20% 5,29% 540.300
03/01/2024 23,38 23,38 22,30 22,55 -3,71% 4,62% 633.100
02/01/2024 22,95 23,50 22,59 23,42 +2,14% 3,97% 532.400
29/12/2023 23,18 23,23 22,78 22,93 -0,86% 1,95% 326.400
28/12/2023 23,36 23,88 23,05 23,13 -1,32% 3,55% 546.000
27/12/2023 23,13 23,48 23,00 23,44 +1,82% 2,08% 484.600
26/12/2023 22,53 23,17 22,42 23,02 +3,51% 3,33% 581.400
22/12/2023 21,99 22,55 21,99 22,24 +2,92% 2,55% 433.300
21/12/2023 21,07 21,70 20,88 21,61 +4,14% 3,89% 624.700
20/12/2023 21,63 21,66 20,71 20,75 -4,82% 4,39% 676.600